PARP inhibitors

PARP1 as a potential biomarker for response to immunotherapy

By Sharon Deveson Kell|2021-10-25T09:31:16+00:0025 Oct 2021|Drug treatments|

In a recent study, the researchers looked at the RNA [...]

Comments Off

Genetic profiling of renal medullary carcinoma paves the way for a potential treatment

By Sharon Kell|2020-06-16T14:25:21+00:0016 Jun 2020|Uncategorized|

Renal medullary carcinoma (RMC) is an aggressive cancer that mainly [...]

Comments Off

PARP inhibitors, vaccines and combination therapies for kidney cancer

By Sharon Kell|2020-01-13T11:47:16+00:0013 Jan 2020|Drug treatments|

In this interview with OncLive, professor Sumanta Kumar Pal from [...]

Comments Off

Potential new treatments for kidney cancer discussed at 2019 Kidney Cancer Research Summit

By Sharon Kell|2019-11-05T09:29:59+00:005 Nov 2019|Drug treatments|

In this interview from the 2019 Kidney Cancer Research Summit [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org